RELX, GB00B2B0DG97

ClinicalKey from RELX plc - real-time updates for hospital teams

28.06.2026 - 02:15:32 | ad-hoc-news.de

ClinicalKey from RELX plc puts continuously updated medical guidelines, drug data and full-text articles into a single search for clinicians at the bedside. This bestseller keeps the price of RELX shares in focus for many institutional investors (ISIN GB00B2B0DG97).

RELX, GB00B2B0DG97
RELX, GB00B2B0DG97

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-28, 02:14. Details in the imprint.

ClinicalKey from RELX plc sits open on a ward computer while a junior doctor scrolls through treatment options with one hand and holds a stethoscope in the other. The interface looks tidy, the search bar large, the urgency very real.

What ClinicalKey actually is

ClinicalKey is a digital clinical reference platform from RELX subsidiary Elsevier that bundles textbooks, journals, guidelines and drug information in one searchable interface for doctors and nurses. It targets hospitals and medical practices that rely on evidence-based decisions.

Instead of hunting through shelves of heavy books, users type a diagnosis or drug name and get summaries, full-text articles and images that they can filter by patient group, specialty or document type. In practice this often cuts minutes off each case discussion and reduces the temptation to rely on outdated PDFs.

Content breadth and depth

According to Elsevier, ClinicalKey includes hundreds of leading medical and surgical textbooks, thousands of journals and millions of images, clinical overviews and drug monographs for a wide range of specialties. Many hospitals license it across departments so surgeons, internists and pediatricians work from the same content base.

Dr. Kieran Walsh, Clinical Director at BMJ and long-time watcher of digital reference tools, has noted in public talks that systems like ClinicalKey only win if they cover both rare and everyday cases convincingly. In daily rounds that means a junior can look up Kawasaki disease and community-acquired pneumonia in the same system without switching context.

Go deeper

Background on RELX shares

ClinicalKey belongs to RELX's long-established information and analytics portfolio, which many institutional investors track through the company’s London listing and steady dividend policy.

Search, filters and workflow

On screen ClinicalKey feels closer to a clinical search console than an e-book shelf. Users enter free-text queries or specific terms, then narrow results with filters for study type, publication year or patient population. The layout stays clean enough that even tired residents can scan it quickly.

For many teams the real win is integration into hospital systems. Librarians like Elsevier’s Louise O’Neill, who often helps configure access, highlight that single sign-on and links from electronic medical records reduce friction: doctors click once from a patient chart and land directly on the matching ClinicalKey topic.

Updates and evidence currency

In medicine, information ages fast. RELX pitches ClinicalKey as a living library, with regular content updates as new trials, guidelines and drug safety notices appear. That rhythm matters when a guideline change can alter antibiotic choices on the same day.

On night shifts this shows up as subtle but crucial differences: a resident pulling up sepsis bundles sees the latest thresholds instead of last decade’s definitions, and the treatment algorithm diagram reflects the current recommended lactate checks and fluid bolus volumes.

How licensing and pricing work

ClinicalKey is sold mainly via institutional subscriptions, with pricing typically based on hospital size, number of users and selected specialties. Larger teaching hospitals often opt for multi-year contracts that bundle additional educational tools for students and residents.

Individual practitioners in some markets can license limited versions via medical societies or national platforms, but the core business remains enterprise-level deals. For RELX this means relatively predictable recurring revenue once a hospital has embedded the tool into its workflow.

Competition and RELX strategy

ClinicalKey competes directly with other clinical reference platforms and evidence-based tools that aim to sit at the point of care. RELX leans on Elsevier’s deep journal and textbook catalog to differentiate, while gradually adding analytics layers and quality-of-care reporting features.

RELX CEO Erik Engstrom regularly stresses in presentations that the group’s edge lies in combining high-quality proprietary content with data analytics and workflow tools. ClinicalKey illustrates that formula clearly: content plus search plus integrations, all wrapped into one subscription.

Where ClinicalKey still frustrates

Users sometimes complain about occasional clutter in search results if queries are too broad, which can mean extra clicks before reaching a concise answer. On busy rounds that extra friction becomes noticeable, especially on slower hospital hardware.

Another point raised in librarian forums is the learning curve for new users who expect a consumer-style search experience. Training sessions and cheat sheets help, but hospital educators still find themselves walking clinicians through lesser-known features such as saving topic lists or exporting images for presentations.

Role in the RELX portfolio and shares

Within RELX, ClinicalKey belongs to the Scientific, Technical and Medical segment, which sits alongside the company’s risk, legal and exhibitions businesses and benefits from the general shift to digital and analytics-led tools. For institutional investors the product underlines how much of RELX’s growth rests on sticky, subscription-based platforms.

The RELX share price is primarily driven by the broader performance of these information and analytics units on the London Stock Exchange, with ClinicalKey contributing as one of several long-running digital offerings.

Key facts on ClinicalKey

  • Product: ClinicalKey
  • Manufacturer: RELX plc
  • Category: Classic clinical reference platform
  • Launch: First introduced in the early 2010s, expanded continuously
  • RRP / Price: Institutional subscription pricing, depending on size and scope
  • Availability: Primarily via hospital, university and practice licenses in many regions worldwide
  • Target group: Physicians, nurses, medical students and clinical librarians
  • Highlight / USP: Combines extensive Elsevier medical content with a single search interface at the point of care

ClinicalKey in media and community

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | GB00B2B0DG97 | RELX | boerse | 69642920 | bgmi